Communication Challenges ID'd in Neonatal Encephalopathy

Share this content:
Communication Challenges ID'd in Neonatal Encephalopathy
Communication Challenges ID'd in Neonatal Encephalopathy

MONDAY, Aug. 8, 2016 (HealthDay News) -- Three themes have been identified as communication challenges in neonatal encephalopathy and therapeutic hypothermia, according to a study published online Aug. 3 in Pediatrics.

Monica E. Lemmon, M.D., from the Johns Hopkins School of Medicine in Baltimore, and colleagues conducted semi-structured interviews with parents whose infants were enrolled in a study of therapeutic hypothermia from 2011 to 2014. Twenty interviews were conducted until thematic saturation was achieved.

The researchers found that three principle themes characterized parental experience of communicating with clinicians. Theme one highlighted a fragmented communication process, which reflected the chaotic maternal and neonatal course. Parents often received key information about neonatal encephalopathy from maternal clinicians; infant medical information was often given to one family member; and the bedside nurse was perceived as the primary source of communication for most families. Theme two included the challenges of discussing such a complex therapy; families were grateful for clinicians who used lay language and provided written material, and reported feeling overwhelmed by technical information. Theme three encompassed the uncertain prognosis following encephalopathy. Parents appreciated being given specific expectations for their infant's long-term development.

"Communicating complex and large volumes of information in the midst of perinatal crisis presents inherent challenges for both clinicians and families," the authors write. "We identified an actionable set of communication challenges that can be addressed with targeted interventions."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »